Pharmaceuticals
Merck & Co in talks to buy Cubist Pharmaceuticals for more than $7 bn
06 Dec 2014
Cubist Pharmaceuticals develops drugs for potentially life-threatening infections caused by dangerous bacteria categorised as serious and urgent public health threats
GSK abandons sale of older drugs portfolio
05 Dec 2014
GlaxoSmithKline's $1.57-bn restructuring to hit US jobs
04 Dec 2014
GSK is struggling with declining sales, especially in the US, mainly due to a fall in its respiratory business, which accounted for 30 per cent of its global sales last year
Ebola virus gives birth to a new vaccine
28 Nov 2014
Over the long term, GlaxoSmithKline's new vaccine is intended to protect against all Ebola outbreaks, and the drug maker hopes to produce one million doses a month of the vaccine by the end of 2015
Medtronic’s $42.9-bn Covidien deal approved by US regulator
27 Nov 2014
Medtronic Inc, the world's fourth-largest medical device maker, has received US regulatory approval to acquire Dublin-based Covidien Plc, subject to the condition that it sells its drug-coated balloon catheter business
Devices maker Stryker mulls $16-bn bid for British peer Smith & Nephew
25 Nov 2014
US medical device maker Stryker Corp is considering structuring the transaction as a tax inversion move, allowing it to move its base to the UK, where the taxes are lower than in the US
US court dumps Ranbaxy’s bid to stall launch of rival generics
20 Nov 2014
Ranbaxy’s move is seen as risky especially since the drug maker has been under regulatory probe for a long period now
Ranbaxy sues US FDA over revoking drug approvals
18 Nov 2014
Generic Nexium and Valcyte together would have contributed about $200 million to Ranbaxy's revenue in the first six months of market exclusivity, say analysts
Actavis in talks to buy US Botox maker Allergan for around $60 billion: report
13 Nov 2014
Last week Allergan had said it was in talks with a suitor, without identifying ithe bidder, which was widely speculated as being Actavis
Featured articles
![](/Uploads/Images/thumb_733d509d-493c-41e9-b429-1260d912bb91-Aerogel-Crayon.jpg)
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
![](/Uploads/Images/thumb_294b0bec-6ff0-43c9-9fbc-a14e7cc70fa5-COP28.jpg)
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
![](/Uploads/Images/thumb_97943c9b-6e8f-429b-b355-1d4502bac437-Ponzi-Money.jpg)
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
![](/Uploads/Images/thumb_0f8359a3-2528-4faf-86c9-707fb7bccc01-Hdfc-logo.jpg)
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
![](/Uploads/Images/thumb_dc6b9dcc-e31e-4574-82e7-928e089406e0-Finger_millet.jpg)
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
![](/Uploads/Images/thumb_e37827da-fafd-4991-8635-60fade3df34c-ICM.jpg)
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation